Bioventus Inc
NASDAQ:BVS
Income Statement
Earnings Waterfall
Bioventus Inc
Revenue
|
502.8m
USD
|
Cost of Revenue
|
-186.7m
USD
|
Gross Profit
|
316.1m
USD
|
Operating Expenses
|
-337.9m
USD
|
Operating Income
|
-21.8m
USD
|
Other Expenses
|
-160.3m
USD
|
Net Income
|
-182.1m
USD
|
Income Statement
Bioventus Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Apr-2021 | Jul-2021 | Oct-2021 | Dec-2021 | Apr-2022 | Jul-2022 | Oct-2022 | Dec-2022 | Apr-2023 | Jul-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||
Revenue |
340
N/A
|
258
-24%
|
316
+22%
|
320
+1%
|
321
+0%
|
324
+1%
|
376
+16%
|
399
+6%
|
431
+8%
|
466
+8%
|
497
+7%
|
517
+4%
|
512
-1%
|
514
+0%
|
511
-1%
|
503
-2%
|
|
Gross Profit | |||||||||||||||||
Cost of Revenue |
(91)
|
(67)
|
(85)
|
(87)
|
(88)
|
(88)
|
(104)
|
(111)
|
(128)
|
(148)
|
(158)
|
(172)
|
(181)
|
(185)
|
(189)
|
(187)
|
|
Gross Profit |
249
N/A
|
191
-23%
|
232
+21%
|
233
+1%
|
234
+0%
|
236
+1%
|
272
+15%
|
289
+6%
|
303
+5%
|
319
+5%
|
339
+6%
|
345
+2%
|
331
-4%
|
329
-1%
|
322
-2%
|
316
-2%
|
|
Operating Income | |||||||||||||||||
Operating Expenses |
(217)
|
(157)
|
(201)
|
(202)
|
(206)
|
(202)
|
(236)
|
(259)
|
(283)
|
(342)
|
(364)
|
(372)
|
(386)
|
(367)
|
(349)
|
(338)
|
|
Selling, General & Administrative |
(198)
|
(140)
|
(176)
|
(180)
|
(188)
|
(182)
|
(215)
|
(235)
|
(254)
|
(306)
|
(326)
|
(336)
|
(333)
|
(327)
|
(312)
|
(303)
|
|
Research & Development |
(11)
|
(8)
|
(11)
|
(11)
|
(11)
|
(10)
|
(12)
|
(15)
|
(19)
|
(25)
|
(27)
|
(25)
|
(26)
|
(22)
|
(19)
|
(17)
|
|
Depreciation & Amortization |
(8)
|
(6)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(10)
|
(11)
|
(11)
|
(21)
|
(15)
|
(15)
|
(15)
|
|
Other Operating Expenses |
0
|
(3)
|
(7)
|
(4)
|
0
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(7)
|
(4)
|
(4)
|
(3)
|
|
Operating Income |
32
N/A
|
34
+7%
|
31
-10%
|
31
+1%
|
27
-12%
|
34
+26%
|
37
+6%
|
30
-19%
|
20
-32%
|
(23)
N/A
|
(25)
-10%
|
(27)
-9%
|
(55)
-102%
|
(38)
+31%
|
(27)
+28%
|
(22)
+20%
|
|
Pre-Tax Income | |||||||||||||||||
Interest Income Expense |
(18)
|
(11)
|
(14)
|
(11)
|
(9)
|
(5)
|
(3)
|
(0)
|
2
|
1
|
(0)
|
(5)
|
(25)
|
(31)
|
(39)
|
(45)
|
|
Non-Reccuring Items |
(4)
|
0
|
0
|
(1)
|
(2)
|
0
|
(4)
|
(11)
|
(10)
|
(11)
|
(6)
|
(128)
|
(196)
|
(210)
|
(210)
|
(87)
|
|
Total Other Income |
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
12
|
(9)
|
(8)
|
(9)
|
|
Pre-Tax Income |
10
N/A
|
23
+134%
|
17
-27%
|
19
+14%
|
16
-16%
|
30
+87%
|
27
-10%
|
15
-43%
|
8
-50%
|
(36)
N/A
|
(34)
+7%
|
(161)
-377%
|
(264)
-64%
|
(287)
-9%
|
(285)
+1%
|
(163)
+43%
|
|
Net Income | |||||||||||||||||
Tax Provision |
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
2
|
7
|
8
|
36
|
51
|
33
|
34
|
4
|
|
Income from Continuing Operations |
8
|
21
|
15
|
18
|
15
|
29
|
24
|
14
|
10
|
(29)
|
(26)
|
(125)
|
(213)
|
(254)
|
(251)
|
(158)
|
|
Income to Minority Interest |
1
|
1
|
1
|
2
|
2
|
2
|
8
|
9
|
10
|
13
|
7
|
34
|
55
|
62
|
63
|
36
|
|
Net Income (Common) |
(1)
N/A
|
18
N/A
|
8
-57%
|
6
-16%
|
4
-31%
|
18
+318%
|
24
+32%
|
20
-17%
|
19
-4%
|
(17)
N/A
|
(20)
-19%
|
(127)
-533%
|
(159)
-25%
|
(287)
-81%
|
(283)
+1%
|
(182)
+36%
|
|
EPS (Diluted) |
-0.01
N/A
|
0.32
N/A
|
0.14
-56%
|
0.12
-14%
|
0.08
-33%
|
0.44
+450%
|
0.58
+32%
|
0.48
-17%
|
0.43
-10%
|
-0.27
N/A
|
-0.33
-22%
|
-2.06
-524%
|
-2.59
-26%
|
-4.61
-78%
|
-4.52
+2%
|
-2.89
+36%
|